Intranasal vaccines are showing promise, but there are multiple formulation hurdles to overcome.

Getting a Nose for Vaccines

The delivery platform depends on API-related factors, and the development stage of the product.

Platform Decisions for Inhalation Drugs

Topic

Articles

CordenPharma will build a clinical trial development facility for manufacture of oral solid dosage drug products at its Plankstadt facility near Heidelberg, Germany.

CordenPharma Adds Highly Potent Capabilities in Germany

Samsung Biologics, GreenLight Biosciences, and Environmental Impact Acquisition Corp. have partnered to advance GreenLight’s mRNA COVID-19 vaccine candidate.

Samsung Biologics, GreenLight Biosciences, and Environmental Impact Acquisition Corp to Build mRNA Vaccine Manufacturing Capacity

The companies are testing their existing vaccines against the new variant of concern and are pursuing variant-specific versions. 

Vaccine Makers Seek to Address Omicron SARS-CoV-2 Variant

The Comirnaty vaccine received a positive opinion from the EMA’s CHMP for children five to under 12 years of age. 

EMA Recommends Pfizer and BioNTech’s COVID-19 Vaccine for Children 

Novavax has announced that EMA has started its review of a conditional marketing authorization application for its COVID-19 vaccine, NVX-CoV2373.

EMA Begins Evaluation of Novavax COVID-19 Vaccine Marketing Authorization Application

Editor of Pharmaceutical Technology Europe

Richard Denk, Senior Consultant Aseptic Processing and Containment, SKAN AG, discusses the evolution of aseptic processing with a particular focus on isolators.

Evolution of Aseptic Processing: INTERPHEX Keynote Part 2

Jennifer Markarian is manufacturing editor of Pharmaceutical Technology.

Gernot Warnke, Head of R&D, JRS Pharma, spoke about excipients and how these relate to feeding in batch and continuous manufacturing. 

Equipment Trends in Advanced Solid-Dosage Drug Manufacturing: INTERPHEX Keynote Part 5

Sharon Nowak, Business Development Manager, Coperion K-Tron USA Food & Pharmaceutical Industries spoke about feeding equipment in solid-dosage drug manufacturing.

Equipment Trends in Advanced Solid-Dosage Drug Manufacturing: INTERPHEX Keynote Part 4

Feliza Mirasol is the science editor for 

Chris Spivey is the editorial director of 

Part 2—Industry experts from MilliporeSigma, Lonza, Astrea Bioseparations, and Sartorius provide insight and examples about solving critical challenges in both analytics and process development for emerging therapies.

Advances in Molecule Characterization and Biomanufacturing for Emerging Therapies: Part 2

Fernando Muzzio, PhD, Distinguished Professor of Chemical and Biochemical Engineering at Rutgers University, spoke about trends in continuous manufacturing of OSD drugs.

Dosage Forms

Getting a Nose for Vaccines

Platform Decisions for Inhalation Drugs